The invention relates to methods of medically treating mammals with Eustachian tube dysfunctions, such as Ménières disease, vertigo, Otitis Media (including Otitis Media with Effusion (OME), Acute Otitis Media (AOM) and Aerotitis Media (AM)) as well as other disorders which are characterized by ET dysfunction.